About.
I’m a data-science executive with 18+ years spanning wet-lab biology, AI/ML engineering, HPC/cloud infrastructure, and leadership across pharma, biotech, and consumer health.
I architected the AlphaMeld™ platform — an end-to-end AI stack that accelerates target triage and indication selection for global drug-makers. My work covers clinical-trial design and enrollment prediction, digital-twin modelling, and large-scale knowledge-graph analytics.
I care about converting multimodal data into real business value, scaling cross-site teams, and forging the kind of partnerships that redefine R&D.
Career
- AlphaMeld GmbH (formerly InveniAI GmbH)nowHead of Data Sciences – Site Head · Basel, SwitzerlandDec 2020 – PresentPythonNeo4jAWSReactLLMsKnowledge Graphs
- — Leads development and deployment of the AlphaMeld Platform.
- — Spearheads strategic AI/ML initiatives to enhance AlphaMeld/AlphaCompass capacity.
- — Advises pharma/biotech companies on leveraging data science methodologies.
- — Applied deep molecular biology expertise for MOA analyses and therapeutic target viability.
- — Manages a data science team of 5 members.
- ArtiXio Pvt LtdnowChief Technology Officer · RemoteSep 2017 – PresentReactNext.jsTypeScriptGPT-4ClaudePostgreSQL
- — Owns technology strategy, architecture, and delivery of Artixio's digital product portfolio — from concept to production.
- — Conceptualized and built QuriousRI, a secure role-based regulatory intelligence platform covering pharmaceuticals, biologics, biosimilars, and generics across 12+ agencies (FDA, EMA, PMDA, NMPA, Health Canada, MHRA, Swissmedic, and more), with AI-assisted document analysis (GPT-4, Claude).
- — Architected additional technology applications for the company, including an AI assistant that mines global regulatory updates and auto-drafts submission dossiers — opening a new non-pharma revenue channel.
- — Directs enterprise-level data science and AI product development using Agile methodologies, ensuring adherence to global regulatory standards (FDA, EMA, ICH) across the drug development lifecycle.
- Apxora GmbHnowCo-Founder & AI/Data Science Head · Basel, SwitzerlandDec 2024 – PresentPythonLLMsReactAWSNeo4j
- — Drives development and deployment of the ResearchNexus and Clinical Navigator platforms.
- — Leads strategic AI/ML initiatives for detecting early innovation signals for emerging targets, novel therapeutics, and healthcare solutions.
- — Supports the Asset Lifecycle Manager and Portfolio Management platforms.
- RenaissThera Pvt LtdnowScientific & AI Advisory Board · RemoteSep 2024 – PresentAI StrategyDrug Discovery
- — Advising on AI-driven strategies for early-stage drug discovery and translational research.
- — Shaping the future of health through regulatory-aware innovation in digital and data sciences.
- Kstych Pvt LtdCo-Founder | Director Data Sciences | Life Science Consultant · Gurgaon, IndiaJul 2012 – Aug 2023PythonRNLPMongoDBHadoopTableau
- — Co-founded and led data sciences, applying statistical, mathematical, and predictive modeling to build algorithms for life-science research questions.
- — Advised pharma and biotech firms on de novo, reformulation, repurposing, and drug-rescue strategies using real-world data.
- — Built statistical predictive models using NLP and machine learning on RWD; led therapeutic target assessment and MOA analysis.
- — Hands-on expertise in Python, R, KNIME, MongoDB, Hadoop, MySQL/MariaDB, Tableau, Gephi, and Cytoscape.
- InveniAI LLCSenior Director of Data Science · Hybrid Gurgaon IN / CT USSep 2017 – Nov 2020PythonAgileData ScienceAI/ML
- — Conceptualized, built, and executed innovative solutions throughout the drug development lifecycle.
- — Managed enterprise-level data science products using Agile methodologies.
- — Established short- to long-term strategies for Data Science and AI teams.
- BioXcel CorporationDirector Data Sciences | Life Science Consultant · Gurgaon, IndiaNov 2010 – Jul 2017Data ScienceDrug RepurposingBig DataStrategy
- — Directed drug repurposing and novel target hypothesis generation using big data and statistical techniques.
- — Advised pharma and biotech firms on diverse scientific strategic projects, surveys, and future opportunity mapping (de novo, reformulation, repurposing, drug rescue) using real-world data.
- — Managed and mentored a team of data scientists; partnered closely with US-based pharma and biotech clients.
- — Led project management and strategy consulting efforts, providing scientific support to business development.
- RanbaxyResearch Biologist · Gurgaon, IndiaJan 2008 – Nov 2010Molecular BiologysiRNADrug Discovery
- — Conducted siRNA targeted gene silencing for target-based drug discovery.
- — Cloning, expression, purification, and activity analysis of human kinases, cytochrome P450 proteins, GPCRs, and bacterial enzymes — supporting enzyme- and cell-based NCE screening assays.
- — Managed experiments using mammalian, baculovirus, and Dictyostelium expression systems.
Education
- University of RajasthanBachelor's Degree, Biotechnology2008
- Bioinformatics Institute of IndiaDiploma, Bioinformatics2004